Literature DB >> 31414913

Incidence of Irvine Gass Syndrome after Phacoemulsification with Spectral-Domain Optical Coherence Tomography.

David Bellocq1,2, Thibaud Mathis1,2, Nicolas Voirin3, Zainab Machkour Bentaleb1,2, Rebecca Sallit1,2, Philippe Denis1,2, Laurent Kodjikian1,2.   

Abstract

Purpose: Incidence of significant and non-significant macular edema found using spectral-domain optical coherence tomography (SD-OCT) following cataract surgery.
Methods: Prospective, cohort series conducted at the Croix Rousse University Hospital. Significant macular edema (SME) was defined as the presence of fluid with an increase of 30% or more in central subfield macular thickness compared to baseline on SD-OCT at 6 weeks and non-significant macula edema (NSME) as an increase of less than 30%.
Results: Nine hundred and twenty-eight eyes in 638 patients were included in the study. Incidence of Irvine Gass (IG) syndrome was 9%, 2.3% of patients presented SME, 6.8% NSME. Epiretinal membrane, diabetes, and capsular rupture were significantly associated with a risk of IG. The risk of developing IG in the fellow eye was 23% in cases of IG in the first eye. In total 8.4% of all included patients developed chronic IG (duration of more than 6 months).
Conclusion: This study reports the incidence of IG during 6 months of surgical activity at a French university hospital center.

Entities:  

Keywords:  Incidence; macular edema; optical coherence tomography

Mesh:

Year:  2019        PMID: 31414913     DOI: 10.1080/09273948.2019.1634215

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Optical Coherence Tomography: Critical Tool to Manage Expectations after Cataract Extraction.

Authors:  Raquel Goldhardt; Bradley Simon Rosen
Journal:  Curr Ophthalmol Rep       Date:  2020-06-06

2.  Transient reduction in macular deep capillary density on optical coherence tomography angiography after phacoemulsification surgery in diabetic patients.

Authors:  Zaowen Wang; Erqian Wang; Youxin Chen
Journal:  BMC Ophthalmol       Date:  2020-08-17       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.